Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613 1623
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18265107 | COMPOSITION CONTAINING RANITIDINE HAVING A LOW IRON CONTENT | Non-Final OA | OPELLA HEALTHCARE GROUP SAS |
| 19337639 | METHOD FOR PRODUCING A LIQUID COMPOSITION INCLUDING A NANOPARTICLE, AND FORMULATION THEREOF | Final Rejection | GLOBAL LIFE SCIENCES SOLUTIONS UK LIMITED |
| 17766445 | OCULAR SEALANTS AND METHODS OF USING THE SAME | Non-Final OA | The Regents of the University of California |
| 17924776 | Methods and Compositions For Reducing Intraocular Pressure | Final Rejection | Georgia Tech Research Corporation |
| 18680005 | DELIVERY OF SURFACTANT SOLUBLE AGENT | Non-Final OA | The Procter & Gamble Company |
| 18010591 | CELLULOSE ACETATE PARTICLES, COSMETIC COMPOSITION, AND METHOD FOR PRODUCING CELLULOSE ACETATE PARTICLES | Final Rejection | DAICEL CORPORATION |
| 17482985 | METHODS FOR TREATING DILATED CARDIOMYOPATHY | Final Rejection | Mars, Incorporated |
| 18581955 | CONTROLLED-RELEASE NICOTINE CHEWING GUM | Final Rejection | Altria Client Services LLC |
| 17223800 | CONTROLLED-RELEASE NICOTINE CHEWING GUM | Final Rejection | Altria Client Services LLC |
| 17993555 | BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS | Final Rejection | The Johns Hopkins University |
| 16603359 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17835000 | ORAL COMPOSITION WITH NANOCRYSTALLINE CELLULOSE | Final Rejection | NICOVENTURES TRADING LIMITED |
| 18710925 | COMPOSITION FOR CLEANSING THE HAIR | Non-Final OA | L'OREAL |
| 18569366 | METHODS AND MATERIALS FOR TREATING CANCER | Non-Final OA | Regents of the University of Minnesota |
| 17395116 | ANTIMICROBIAL SHAPE MEMORY POLYMERS | Final Rejection | THE TEXAS A&M UNIVERSITY SYSTEM |
| 17251579 | STABLE CO-FORMULATION OF BENZOYLUREA WITH PYRETHROIDS | Non-Final OA | UPL LTD |
| 17789104 | SILICA MICROCAPSULES | Non-Final OA | KAO CORPORATION |
| 17323659 | IN SITU GELLING POLYSACCHARIDE-BASED NANOPARTICLE HYDROGEL COMPOSITIONS, AND METHODS OF USE THEREOF | Final Rejection | McMaster University |
| 18533542 | THIN-SHELL POLYMERIC NANOPARTICLES AND USES THEREOF | Final Rejection | Academia Sinica |
| 17611705 | ISOTROPIC LIQUID CLEANSERS COMPRISING ACYL ISETHIONATE AND METHYL ACYL TAURATE SURFACTANT MIXTURES | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18554018 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | Non-Final OA | Encapsys, LLC |
| 18475472 | Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives | Non-Final OA | Encapsys, LLC |
| 18462537 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | Non-Final OA | Encapsys, LLC |
| 17529554 | Poly Acrylate and Poly(Beta-Amino Ester) Capsules with Enhanced Degradability | Non-Final OA | Encapsys,LLC |
| 17423669 | Covered Stent For Local Drug Delivery | Final Rejection | BIOTRONIK AG |
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | Non-Final OA | JINWOO BIO CO., LTD. |
| 17420507 | NANOPARTICLES AND PREPARATION METHOD | Non-Final OA | Université Paris-Saclay |
| 18034617 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Final Rejection | Givaudan SA |
| 18011018 | A METHOD OF REDUCING SKIN IRRITATION, COMPRISING THE APPLICATION TO THE SKIN OF AN ALPHA-BISABOLOL PREPARED BY A BIOTECHNOLOGICAL PROCESS | Final Rejection | Givaudan SA |
| 18698796 | DEGRADABLE INTRAUTERINE SYSTEM FOR THE PROLONGED RELEASE OF AN ACTIVE INGREDIENT IN THE UTERINE CAVITY | Non-Final OA | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE MONTPELLIER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy